CareStart™ Covid-19 Antigen
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in anterior nares swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider.
-
FAST
Detect active infection status in 10 minutes.
-
CONVENIENT
No lab equipment or additional instrument required.
-
EASY TO USE
Lower nasal swab collection enables comfortable specimen collection.
-
Manufactured in the USA
Manufactured in the U.S. by a U.S. headquartered company
Point-Of-Care (POC) Designated Test
As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.
FDA EMERGENCY USE AUTHORIZATION (Revision 3/21)
Bloomberg: FDA Approval for CareStart™
Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)
Reagents & Materials Provided
Kit Component / Amount Per Kit
Test Devices / 20 ct.
Assay buffer / 20 ct.
Extraction vials and caps / 20 ct.
Specimen collection swabs / 20 ct.
1 Positive and 1 Negative control swab
Instructions for Use / 1 ct.
